In vitro metabolic profiling of weight-loss-inducing amylin receptor agonists in the context of preventive doping research.
- DOI
- 10.1016/j.jpba.2026.117418
- Published
- 2026 Jun 15
- Container
- Journal of pharmaceutical and biomedical analysis
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jpba.2026.117418,
title = {In vitro metabolic profiling of weight-loss-inducing amylin receptor agonists in the context of preventive doping research.},
author = {Alhalabi H and Borschel L and Le Foll C and Thomas A and Bally L and Thevis M},
year = {2026},
journal = {Journal of pharmaceutical and biomedical analysis},
doi = {10.1016/j.jpba.2026.117418},
url = {https://doi.org/10.1016/j.jpba.2026.117418}
}RIS
TY - JOUR TI - In vitro metabolic profiling of weight-loss-inducing amylin receptor agonists in the context of preventive doping research. AU - Alhalabi H AU - Borschel L AU - Le Foll C AU - Thomas A AU - Bally L AU - Thevis M PY - 2026 JO - Journal of pharmaceutical and biomedical analysis DO - 10.1016/j.jpba.2026.117418 UR - https://doi.org/10.1016/j.jpba.2026.117418 ER -
APA
H, A., L, B., C, L. F., A, T., L, B., & M, T. (2026). In vitro metabolic profiling of weight-loss-inducing amylin receptor agonists in the context of preventive doping research.. Journal of pharmaceutical and biomedical analysis. https://doi.org/10.1016/j.jpba.2026.117418
Source records
- pubmed · retrieved 2026-09-25T13:45:01.295Z